Key Performance Indicators of Secondary Health Care in Chronic Kidney Disease: Experience in Public and Private Services in the State of São Paulo, Brazil

被引:0
作者
Samaan, Farid [1 ,2 ,3 ]
Vicente, Cristiane Akemi [2 ]
Pais, Luiz Antonio Coutinho [2 ]
Kirsztajn, Gianna Mastroianni [4 ]
Sesso, Ricardo [4 ]
机构
[1] State Dept Hlth Sao Paulo, Planning & Evaluat Grp, BR-01246901 Sao Paulo, Brazil
[2] Hapvida Notre Dame Intermed Grp, Special Programs, BR-03164140 Sao Paulo, Brazil
[3] Dante Pazzanese Cardiol Inst, Res Div, BR-04012909 Sao Paulo, Brazil
[4] Univ Fed Sao Paulo, Nephrol Div, Sao Paulo, Brazil
关键词
chronic kidney disease; multidisciplinary care; quality indicators in health care; secondary health care; supplementary health; unified health system; OUTCOMES; SURVEILLANCE; MANAGEMENT; COVERAGE; CKD;
D O I
10.1155/2024/5401633
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The objective of this study was to evaluate quality indicators of secondary health care in chronic kidney disease (CKD). Methods: This retrospective longitudinal study was conducted in an outpatient medical nephrology clinic of the Brazilian Unified Health System (UHS) and a multidisciplinary outpatient clinic of a private health plan (PHP). The inclusion criteria were age >= 18 years, >= 3 medical appointments, and follow-up time >= 6 months. Results: Compared to PHP patients (n = 183), UHS patients (n = 276) were older (63.4 vs. 59.7 years, p=0.04), had more arterial hypertension (AH) (91.7% vs. 84.7%, p=0.02) and dyslipidemia (58.3 vs. 38.3%, p<0.01), and had a lower estimated baseline glomerular filtration rate (eGFR) (29.9 [21.5-42.0] vs. 39.1 [28.6-54.8] mL/min/1.73 m2, p<0.01). Compared to PHP patients, UHS patients had a lower percentage of diabetics with glycated hemoglobin < 7.5% (46.1% vs. 61.2%, p=0.03), fewer people with potassium < 5.5 mEq/L (90.4% vs. 95.6%, p=0.04), and fewer referrals for hemodialysis with functioning arteriovenous fistula (AVF) (9.1% vs. 54.3%, p<0.01). The percentages of people with hypertension and blood pressure < 140 x 90 mmHg were similar between the UHS and PHP groups (59.7% vs. 66.7%; p=0.17), as was the percentage of people with parathyroid hormone control (85.6% vs. 84.8%; p=0.83), dyslipidemia and LDL-cholesterol < 100 mg/dL (38.3% vs. 49.3%; p=0.13), phosphorus < 4.5 mg/dL (78.5% vs. 72.0%; p=0.16), and 25-OH-vitamin-D > 30 ng/mL (28.4% vs. 36.5%; p=0.11). The crude reduction in eGFR was greater in the UHS group than in PHP (2.3 [-0.1; 5.9] vs. 1.1 [-1.9; 4.6] mL/min/1.73 m2; p<0.01). In the multivariate linear mixed-effects model, UHS patients also showed faster CKD progression over time than PHS ones (group effect, p<0.01; time effect, p<0.01; interaction, p<0.01). Conclusions: Quality of care for patients with CKD can be improved through both services, and multidisciplinary care may have a positive impact on the control of comorbidities, the progression of CKD, and the planning of the initiation of hemodialysis.
引用
收藏
页数:10
相关论文
共 42 条
  • [11] Fontenelle LF, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00141515, 10.1590/0102-311x00141515]
  • [12] Relationship between compliance with management target values and renal prognosis in multidisciplinary care for outpatients with chronic kidney disease
    Imamura, Yoshihiko
    Takahashi, Yasunori
    Takeuchi, Takato
    Iwamoto, Masateru
    Yamauchi, Miki
    Nakamura, Rie
    Ogawara, Yuka
    Takeba, Kazuyo
    Shinohara, Makoto
    Joki, Nobuhiko
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (08) : 750 - 759
  • [13] Effect of multidisciplinary care of dialysis initiation for outpatients with chronic kidney disease
    Imamura, Yoshihiko
    Takahashi, Yasunori
    Uchida, Satoru
    Iwamoto, Masateru
    Nakamura, Rie
    Yamauchi, Miki
    Ogawara, Yuka
    Goto, Mikiko
    Takeba, Kazuyo
    Yaguchi, Naomi
    Joki, Nobuhiko
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (07) : 1435 - 1444
  • [14] Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials
    Jun, Min
    Lv, Jicheng
    Perkovic, Vlado
    Jardine, Meg J.
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2011, 2 (04) : 265 - 278
  • [15] Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease
    Ketteler, Markus
    Ambuhl, Patrice
    [J]. JOURNAL OF NEPHROLOGY, 2021, 34 (05) : 1405 - 1418
  • [16] kidney.org, 2020, Chronic Kidney Disease (CKD) Management in Primary Care, V4th
  • [17] Epidemiology of chronic kidney disease: an update 2022
    Kovesdy, Csaba P.
    [J]. KIDNEY INTERNATIONAL SUPPLEMENTS, 2022, 12 (01) : 7 - 11
  • [18] Combination therapy improves survival after acute myocardial infarction in the elderly with chronic kidney disease
    Krause, MW
    Massing, M
    Kshirsagar, A
    Rosamond, W
    Simpson, RJ
    [J]. RENAL FAILURE, 2004, 26 (06) : 715 - 725
  • [19] A New Equation to Estimate Glomerular Filtration Rate
    Levey, Andrew S.
    Stevens, Lesley A.
    Schmid, Christopher H.
    Zhang, Yaping
    Castro, Alejandro F., III
    Feldman, Harold I.
    Kusek, John W.
    Eggers, Paul
    Van Lente, Frederick
    Greene, Tom
    Coresh, Josef
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 150 (09) : 604 - 612
  • [20] Kidney Health for Everyone Everywhere - From Prevention to Detection and Equitable Access to Care
    Li, Philip Kam-Tao
    Garcia-Garcia, Guillermo
    Lui, Siu-Fai
    Andreoli, Sharon
    Fung, Winston Wing-Shing
    Hradsky, Anne
    Kumaraswami, Latha
    Liakopoulos, Vassilios
    Rakhimova, Ziyoda
    Saadi, Gamal
    Strani, Luisa
    Ulasi, Ifeoma
    Kalantar-Zadeh, Kamyar
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2020, 51 (04) : 255 - 262